Roche Diagnostics is part of one of the world’s leading research-oriented healthcare organizations—the Roche Group. Active in the fields of pharmaceuticals and diagnostics, Roche develops innovative products and services that address the prevention, diagnosis and treatment of diseases, thus enhancing well being and quality of life.
About Roche Diagnostics
At Roche Diagnostics, our focus is to improve the lives of patients, from research to lab tests to personalized healthcare; we touch the entire spectrum of diagnostics users. Roche Diagnostics is a member of the Roche Group, which is headquartered in Basel, Switzerland.
Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management.
Roche’s personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients.
In 2010, Roche had over 80,000 employees worldwide and invested over 9 billion Swiss francs in R&D. Roche Diagnostics’ North American headquarters, located in Indianapolis, has about 4,200 employees and is home to U.S. research and development, laboratory, manufacturing, distribution, information technology and administrative operations.